Frontier Pharma Alzheimer’s Disease and Associated Indications Frontier Pharma Alzheimer’s Disease and Associated

Frontier Pharma: Alzheimer’s Disease and
Associated Indications - Exceptional Level of
First-in-Class Innovation within AD, and
Diverse Range of Therapies in Development
for Disorders Such as Anxiety and
Depression
“Alzheimer’s disease (AD), the most common form of
dementia, is a progressive, neurodegenerative and
currently incurable disease characterized by loss of
memory and other mental abilities.”
Summary
Alzheimer’s disease (AD), the most common form of dementia, is a progressive, neurodegenerative
and currently incurable disease characterized by loss of memory and other mental abilities. It has a
devastating impact on independence and quality of life, with patients requiring full-time care in the
later disease stages. In addition to cognitive impairment, AD is associated with behavioral and
psychological changes, which often represent the greatest challenges for patients and caregivers.
The prevalence of AD is escalating rapidly, largely owing to aging populations, as advancing age is
the most important epidemiological risk factor for the disease. This will amplify the already
substantial societal and economic costs of the disease over the coming years.
Read Complete Report with TOC @ http://www.radiantinsights.com/research/frontier-
pharma--alzheimers-disease-and-associated-indications
Follow Us: